← SynDRA
CI-966
SynDRA canonical compound SYN1955455 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | SLC6A1 |
|---|
| Mechanism of action | GAT inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- 1-[2-[Bis[4-(trifluoromethyl)phenyl]methoxy]ethyl]-1,2,5,6-tetrahydropyridine-3-carboxylic acid hydrochloride
Look up CI-966 in the interactive SynDRA portal →